Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
Deadline |
Title | Funding Agency | Discipline | Who's Eligible | Award Amount | Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 11/02/2021 | Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/09/2021 | Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/09/2021 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 11/18/2021 | Pediatric Centers of Excellence in Nephrology (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 12/06/2021 | Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 1/01/2022 | Notice of Intent to Publish a Suite of Funding Opportunity Announcements (FOAs) for the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/07/2022 | Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/21/2022 | Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/25/2022 | Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $900,000 | 4/18/2022 |
| Deadline: 1/26/2022 | Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/31/2022 | Notice of Special Interest (NOSI): Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2022 | Research on Chronic Overlapping Pain Conditions (R01, R21) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2022 | Notice of Special Interest (NOSI) in Migraine and Headache Research | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/08/2022 | Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,200,000 | 4/18/2022 |
| Deadline: 3/03/2022 | Notice of Special Interest (NOSI): Limited Competition for Administrative Supplements to Accelerate the Development of a Translational Research Resource Platform for Advancing Maternal Precision Therapeutics | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 3/07/2022 | Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 3/08/2022 | Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/09/2022 | The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/10/2022 | HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/10/2022 | HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01, R34 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
